Maglasang, John Prince H.
HRN: 25-61-29 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/05/2024
CEFTRIAXONE 1G (VIAL)
08/05/2024
08/11/2024
IV
2gm
Q24
Severe Leptospirosis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes